Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $683,583 - $774,625
-11,839 Closed
0 $0
Q2 2020

Aug 03, 2020

SELL
$54.82 - $64.09 $162,267 - $189,706
-2,960 Reduced 20.0%
11,839 $696,000
Q1 2020

Jun 11, 2020

SELL
$46.4 - $67.43 $689,457 - $1 Million
-14,859 Reduced 50.1%
14,799 $825,000
Q4 2019

May 14, 2020

BUY
$49.21 - $64.19 $1.46 Million - $1.9 Million
29,658 New
29,658 $1.9 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.